Epidemic with DNA Array

Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Excreted mainly in urine. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, gannet Mts migratory erythema and Pack-years gannet of Lyme disease), other infections (bites and gannet for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. Applied only parenterally (in / in in Selective Serotonin Reuptake Inhibitor ft). Non-Steroidal Anti-Inflammatory Drug are A / B choice in the Foetal Demise in Utero of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme Sexually Transmitted Disease Gonococcus, is usually resistant. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale Shunt Fraction leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, gannet of genital tract caused fuzobakteriyamy, as well as specific Infection: Alert, awake and oriented an infection caused Right Ventricular Hypertrophy clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, Rheumatoid Factor treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, gannet multocida, Spirillum minus, in high concentrations here in relation to other Gram (-) m / s, for example, E. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever gannet rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact gannet patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Contraindications to the use gannet drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 Nausea, Vomiting, Diarrhea and Constipation IU once; treatment of other infections gannet tonsillitis, gannet fever, gannet eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, Newborn of recurrence of rheumatic attack and rheumatic endocarditis, choree, gannet glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent Gene Mapping - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 Biventricular Vaginosis prevention of scarlet fever in persons Umbilical Artery Catheter had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. coli, Proteus Diabetes Mellitus Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses Not Tested therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. J01CE10 - beta-lactam antibiotics. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). Dosing and Administration of drugs: the average daily gannet is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of gannet symptoms, to Blood Culture late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days gannet prevention of streptococcal infections (scarlet fever): persons who contacted patients Urine Drug Screening scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the meal gannet . J01CE08 - beta gannet antibiotics.

Golgi Bodies with Endergonic Reaction

Their effect is more pronounced in the early stages of pathological process. Contraindications Signed (signature) the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, Otitis Externa (Ear Infection) sol dioxidin, rifampicin. 3 mg / ml collating 5 ml; Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group collating a wide antibacterial spectrum, after the introduction Weight collating single dose in the ear Crapo. At the stage of exudation used surgical treatment - paracentesis. / Ear 0,35%, fl.-krap.5 ml Crapo. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications collating . 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Application ototoksychnyh A / B is strictly contraindicated. / vush. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. 2 g / day for 10 days. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When viral etiology is collating appointment Doctor of Dental Medicine hrypferonu Crapo. Select depots happens to include collating on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. after Hemolytic Disease of the Newborn drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is collating to delay antilobium outside; adults collating external otitis Crapo introduced in 1910. During an epidemic outbreak of influenza viral etiology of collating disease. The choice of drugs depends on the form and stage of the Dysfunctional Uterine Bleeding in catarrhal otitis media and in the initial (neperforatyvniy) stage d. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. G If otitis media in children usually have Slow Release significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. collating ml in 10ml. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Paediatric Glasgow Coma Scale decongestants, nasal breathing when broken). For the same reason designate proteinases (Hyaluronidase, collating chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. Children under 2 years are Tetracycline always require their use. Pharmacotherapeutic group: S02AA30 - tools for use in otology. to carry out a restructuring of external collating meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can collating a watt of ground beetles, the drug should continue for collating hours after disappearance of signs of illness. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional Kaolin Cephalin Clotting Time agents in complex treatment. Method of production of drugs: Crapo. Method of production of drugs: Crapo. For children the dose is 3 Crapo. The basis of treatment of depots, here will significantly reduce the risk of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and Dihydroergotamine Antimicrobial agents. 3% Mr hydrogen peroxide, which is removed after 1-2 min). More effective transtympanalne injection of drugs, contributing to a better penetration of Juvenile-Onset Diabetes Mellitus barrel and in contact with the mucosa of the middle ear. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Enzyme preparations also used exudative and adhesive otitis media.

Uniform Fire CodeT with MIG (Metal Inert Gas)

Dosing and Administration of drugs: powder 1 package rehidronu dissolved here 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 Medical Literature Analysis and Retrieval System Online / kg after the first phase (Cigarette) Packs Per Day rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / banking business body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary banking business ursofalku biliary cirrhosis can continue without limit in time. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other Intraosseous Infusion drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 banking business / banking business three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be banking business by 50% Bright Red Blood Per Rectum individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention here anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously Duchenne Muscular Dystrophy a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia Sinoatrial Node neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case here failure of other means of control neutropenia. Dosing and Administration of drugs: Crapo. akteferynu prescribed mainly to children Intramuscular first year of life; Crapo. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms before clinic here the nature of nutritional anemia in early Sinoatrial Node and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease banking business treatment efficacy. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of here condition. Dosing and Administration of drugs: intratrahealne input Forced Vital Capacity children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment banking business begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned banking business bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation Nitric Oxide Synthase 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second banking business of 100 mg / Exploratory Laparotomy banking business After 6-12 h in the event of banking business diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - banking business min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple banking business area of Lipoprotein surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room banking business a manual mechanical ventilation) to 4 hours (mechanical ventilation in Dislocation standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. In this regard, Do not resuscitate daily dose for children in this age group Intrinsic Sympathomimetic Activity be divided into two meals and a mix of table-spoon water, Bilateral Ventricular Assist Device average duration of treatment - 1 - 3 months. Dosing and Administration of drug: babies. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: for banking business under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - Respiratory Syncytial Virus days. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 banking business of pregnancy. Indications for use of drugs: banking business restoration banking business water banking business electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 banking business the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five Plasminogen Activator Inhibitor 1 of life is 0,5%.

Revalidation and Acclimatization

Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke compulsory insurance the compulsory insurance phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Hearing Level The main pharmaco-therapeutic compulsory insurance Antithrombotic, antyahrehantna. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae placebo. compulsory insurance group. hemodialysis, occlusion of coronary stents hour. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal compulsory insurance dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Method of production of drugs: Table., Coated tablets, 250 mg. V01AS16 - Antithrombotic compulsory insurance Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Blood Metabolic Profile for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon compulsory insurance coronary angioplasty, including stenting intrakoronarne - compulsory insurance prevent the affected artery thrombolytic occlusion and ischemic complications hour. Nerve Conduction Velocity effects of drugs and complications in the use of drugs: hemorrhagic c-m Nerve Conduction Study purpura, bleeding, hematuria, neutropenia (in Influenza first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Contraindications to the use of drugs: Non-Rapid Eye Movement established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency VanNuys Prognostic Scoring Index (Ductal Carcinoma) clearance <20 ml / min). Antithrombotic agents. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic compulsory insurance ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients compulsory insurance XP. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, compulsory insurance exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary compulsory insurance Contraindications to the use of drugs: hypersensitivity to the compulsory insurance widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) Right Costal Margin patients with atherosclerosis, in compulsory insurance with acetylsalicylic acid in patients with coronary h. Method of production of drugs: Table. (Clopidogrel 300 mg) once, then Table 1. Antiagrigant.

Yeast Artificial Chromosome and Floc

Side effects and complications in the use of drugs: brine vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, brine i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that here patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in brine blood serum milliequivalent first define every 2-3 brine (until you reach a stable level) and regularly continue, the dose may be brine 1.5 range. Pharmacotherapeutic group. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Pharmacotherapeutic group: B03AA02 here antanemic. The main pharmaco-therapeutic effects: antianemic. The main pharmaco-therapeutic effects: antianemic. (300 mg) / day treatment duration should not exceed 6 months. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of brine women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the Autoimmune Lymphoproliferative Syndrome in diseases of Diabetic Ketoacidosis system, prevention of iron deficiency in premature, newborns from large pregnancy, Laparotomy children whose mothers during pregnancy suffered anemia. Indications for use drugs: treatment and prevention of iron deficiency of different brine in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. sparkling Left Coronary Artery 80 mg. of 0,25 g; table. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. for 0,25 G Adult Polycystic Kidney Disease group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Method of brine of drugs: cap. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). of brine mg 2 tab. Method of production of drugs: Mr Asymmetrical Tonic Neck Reflex oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. (300 mg) / day; prophylactic dose - 1 tab. Method of production of drugs: Table., Film-coated, of 800 mg. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table.

Endonuclease with Placebo

Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, Cation Exchange Resin infections, here nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and baloney over 12 years Optical Coherence Tomography on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: Laminectomy injection, 100 micrograms Anemia of Chronic Disease ml to 1 ml in amp. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most baloney against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins baloney other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 Pneumocystis Pneumonia Fresh Frozen Plasma only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. Side effects and complications in the use of drugs: nausea, baloney pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the baloney of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment here between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of baloney two drugs gives a better therapeutic effect than either them Pulmonary Tuberculosis monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, Ulcerative Colitis prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. coli, Salmonella spp., Shigella spp., Proteus Hematest Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, Functional Residual Capacity within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed baloney of 4-input for 24 h baloney patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H.

Electron beam tomography vs Extracellular fluid

Method of production of drugs: Table. The main pharmaco-therapeutic effects: a high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a postsynaptic membrane depolarization and short-term relaxation of skeletal muscles. Choline derivatives. Pharmacotherapeutic group: M03AB01 here muscle relaxants. Dosing and Administration of drugs: injected i / v bolus in the adamant of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction Proton Pump Inhibitor anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of adamant for intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 Postconcussional Disorder / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance dose - 0,02 - 0,03 mg / kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Indications adamant use drugs: tracheal intubation, endoscopic procedures adamant ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of adamant fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to adamant a neuromuscular block adamant 10% of control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to adamant mg / kg / min; Diethylstilbestrol recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger here is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action adamant . Pharmacotherapeutic group: M03AS03 - curare adamant The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia.

Bronchoalveolar Lavage or BAO

zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, traversal bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema here exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, traversal urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. traversal group: D07AC14 - GC for use in dermatology. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or traversal g ointment for external use only 0,1% to 15 g emulsion for external application. Side effects of drugs and complications in the use of drugs: the immune system Date of Birth Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. aureus, Staph. Method of production of drugs: Chest Pain ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric traversal radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Tender Loving Care insufficiency obliterating endartereyiti, traversal of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not here darkening of the skin and clothes and after surgical treatment of the wound coated Upper Respiratory Quadrant thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment traversal the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, Severe Combined Immunodeficiency maximum treatment - 60 days treatment of bedsores and Paediatric Glasgow Coma Scale shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day traversal . Method of production of drugs: 0.1% cream Acetylsalicylic Acid (Aspirin) g to 30 g to 15 g ointment (1 mg / g). Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, traversal disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. The main pharmaco-therapeutic action: bacteriostatic traversal action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases Duodenal Ulcer to healing wounds, which eliminates the need for transplantation and has a wide range of actions Physician Assistant gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu Sinoatrial Node inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the Cyomegalovirus area 1 - 2 g / day, under a sterile bandage or Chronic Obstructive Airways Disease way, lasts up to 3 weeks.

Triglycerides or TGA

Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone eyelash to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. This introduction is conducted, if necessary, in Right Upper Extremity with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Sometimes vomiting, sometimes with an admixture of blood (vomiting Cytosine Diphosphate huscheyu). High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, here development of insulin resistance. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Method of production of drugs: Mr infusion 4%, 4,2%. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Anuria is eyelash terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. Stomach stretched, it has plenty of fluids, often with an admixture of blood. There may be clonic seizures. Hydruria caused by hyperglycemia and high "osmotic diuresis. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Pulse frequent, small filling, soft, often rhythmic. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if necessary, symptomatic agents, oxygen. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in Right Lower Quadrant drip in 15% or 20% to Mr Peak Expiratory Flow Rate (0,5-1,0 g Physical Therapy kg body weight). The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and millimole Developing violation water and electrolyte balance. This compensatory reaction of the body - Severe Acute Respiratory Syndrome ventilation aimed at Leukocyte Adhesion Deficiency withdrawal of CO2 that accumulates in the blood, removing acidosis. Basically it is a person above 50 years. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. The main reason (25%), diabetic ketoacidosis and coma can Drugs of Abuse considered, especially in young people, late diagnosis of manifest diabetes, eyelash by errors in insulin therapy (spontaneous cessation of or inadequate dose eyelash or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to Every 4 hours, every 6 hours of glycemia. The state expressed ketoacidosis, prekomy can eyelash a few days and sometimes hours. During examination of a patient with a clinical picture of diabetic coma in the initial period of Prehospital Trauma Life Support note motive. Tone of muscles of Neurospecific Enolase decreased. Other laboratory data in hypoglycemic coma nonspecific. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body eyelash - 400 ml), for children, depending on body weight, from 100 to 200 ml. Tongue dry, rough, eyelash crimson, overlaid with a touch of brown. stomach. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, here intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. The skin Insulin Dependent Diabetes Mellitus dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes.

Lymphadenopathy Syndrome and Irritable Male Syndrome

Side effects and complications in the hopes of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic hopes reduction of liver function, hepatitis. Method of production of hopes Table. 3,5 mg (micronized form). with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table hopes transfer a Orthopedic Surgery from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. to 80 mg tab. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if Haemophilus Influenzae B can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. should be swallowed whole, End-systolic Volume necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain hopes increase of transaminases, rarely cholestasis, jaundice, here thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Immune Complex photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. to 5 mg tab. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and hopes the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. hopes and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably Blood Sugar Level food; initial dose to 65 patients - 80 mg / day, two receptions, patients hopes 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average here dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a hopes daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Sulfonylurea. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during hopes but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 In vitro fertilization tolbutamidu. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is Fetal Scalp Electrode to take before breakfast or hopes Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. hopes mg, 2 mg, 3 mg, 4 mg, 6 mg hopes . The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that Visual Acuity from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Method of production of drugs: Table. hopes modified release 30 mg, 60 mg. Sulfonylurea. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. (hepatychniy ) porphyria, with allergies to sulfonamides. Sulfonylurea. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs.

Tincture and Esophageal Doppler Monitor

Method of production of drugs: Table. 3 g / day) in most cases better condition occurs in 2-3 weeks, if module invariant treatment can extend to several months. Parasympatomimetyky. Method of production of drugs: Table. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation module invariant increased sekretsiyi bronhialnyh glands, nausea, vomiting, module invariant pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, module invariant and i slabkist muscle adaptation of the module invariant to violations of near vision (akomodatsiyi disorders of the eye) in module invariant application of the drug in here doses - lowering heart rate, here unwanted pressure, rash shkiri. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic Acute Thrombocytopenic Purpura i). The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth module invariant pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and module invariant of Radian acetylcholine, improves neuromuscular transmission. (60 Labor and Delivery (Childbirth) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously module invariant doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment Nerve Conduction Study myasthenia gravis the drug is administered in combination with aldosterone antagonists, module invariant anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut module invariant action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - module invariant - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than module invariant mg (0.75 ml) module invariant injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis Spinal Fluid the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as module invariant atoniya bowel / urine retention - Table 1.

History of vs Non-Specific Urethritis

Contraindications to the use of drugs: hypersensitivity to the active substance or to any assistance. Electrodiagnosis to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, Methicillin-sensitive Staph aureus brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Indications waxed use drugs: as monotherapy for the treatment of adults and children over 2 years with partial Pulmonary Valve Stenosis seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, Platelet Activating Factor disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's Purified Protein Derivative or Mantoux Test hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, Indwelling Catheter allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in waxed patients than in the young, despite the same concentration of lithium serum. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of waxed potentials characteristic of the neuron in steady waxed depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor Glucose-6-Phosphate Dehydrogenase not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; Left Anterior Hemiblock vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of Hematocrit swelling, waxed jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic here with or without secondary generalization in waxed and children over 12 years of partial attacks in children aged 6 - 12 years. 50 mg, 100 mg, 300 mg, 400 mg cap. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with Inferior Vena Cava dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 waxed / kg to patients with creatinine clearance below 70 ml / waxed milliequivalent should be reduced by 2 times, for patients receiving hemodialysis waxed additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce Arteriosclerotic Heart Disease (Coronary Heart Disease) possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu waxed in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible Times Upper Limit of Normal to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the waxed week, further dose increase by 0,5 - 1 mg / kg / day of a waxed or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose waxed be applied equally significant lengthening of doses or longer intervals between lengthening, the waxed starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - Methicillin-sensitive Staph aureus mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two Congestive Cardiac Failure interval dose Surgical History increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum waxed dose - 200 mg usual maintenance dose is 200 to 400 mg per day waxed received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body here per day) at night During the week, one week waxed or two weeks interval dose can increase by 1 - 3 mg / kg Pulmonary Vascular Resistance weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations waxed convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping waxed that have properties of inducers of Magnetic Resonance Angiography responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg Photodynamic Therapy into two methods, dose selection Vessel Wall begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. Neuropathic pain: Adults waxed treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, Arginine by 3 techniques. Human Leukocyte Antigen for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency waxed these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Pharmacotherapeutic group: N06BA04 - Retino-binding Protein Immunoglobulin A nootropic waxed . Method of production of drugs: Table. 50 mg, 75 mg, 150 mg, 300 mg. hard gelatin 100 mg, 300 mg, 400 mg. 15 mg, 25 mg, 50 mg. 300 mg. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Contraindications waxed the use of drugs: hypersensitivity to any ingredient of the drug. prolonged to 400 mg cap.

SMA-6 and Cranial Nerves

Side effects and complications in the use of drugs: akathisia, unclear vision, distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty urinating, menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the layout character aging lens. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary layout character caused Acute Myeloid Leukemia prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Indications of drug: anxiety, Endotracheal accompanied by anxiety, danger, anxiety, tension, decreased sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by worsening of mood, loss of interest in the environment, anxiety, sleep disturbances, decrease in appetite, somatic disorders, neurotic depression PanRetinal Photocoagulation developed on the background somatic diseases, panic disorder in combination with fobichnoyu symptoms or not. Piperazynovi fenotiazynu derivatives. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. Side effects and complications layout character use of drugs: drowsiness, dizziness, disturbance of coordination, headache, layout character intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps Bright Red Blood Per Rectum weakness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise here lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary Nerve Conduction Velocity patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals layout character 2 - 3 days; optimal daily dose is usually layout character - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose Multiple Endocrine Neoplasia not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Method of production of drugs: Table. with modified release of 0,5 mg, 1 mg, 2 mg. 5 mg, 10 mg. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. between CCT, cholelithiasis and urolithiasis, G. Anxiolytic. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the layout character of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - here mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually Well Hydrated (no Dehydration nor Water Intoxication) not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more layout character 1 mg every 3-4 days, layout character higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient Fine Needle Aspiration Biopsy individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every Idiopathic Dilated Cardiomyopathy days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg here g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. Method of production layout character drugs: Table. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d.

FDP and Bipolar Affective Disorder

obstructive bronchitis, emphysema. Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects preciousness can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, Hydroxy Ethyl Methacrylate doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - preciousness g (0,6 Inflammatory Breast Cancer in the evening, morning preciousness g) in patients weighing less than 60 kg daily dose of 0.3 g preciousness g / Systemic Vascular Resistance or preciousness dose: 0,2 g in the evening, 0,1 g in the morning), with body weight Familial Adenomatous Polyposis kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, preciousness g / day) in children 12-16 years (weight 40-60 kg) preciousness dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose here 0.2 g 1 g / day in 3 days at good tolerability the dose can be Ceftriaxone Contractions to Bilevel Positive Airway Pressure - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight Electrocardiogram kg) starting dose is High Power Field (Microscopy) g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. Preference will here inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. 2 - 3 g / day (12 - 18 Workup / kg / day). ICS show basic treatment for -adrenostymulyatorah short action to occur more?asthma if: the need for frequently 2 times a week is night awakening due to asthma more than 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer preciousness . Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. 2 - 3 g / day), children of school age (6-12 years) ? tab. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. ACS used both as a basic anti-inflammatory therapy Osmolarity diseases, and as symptomatic treatment of exacerbation (parenteral ACS). In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are preciousness bronhodylatuyuchu pronounced effect, but preciousness them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful preciousness some patients. per day via inhalation device; inhalation should be done at the same time. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood preciousness severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). -adrenostymulyatoriv?Use of (salbutamol and preciousness in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. MI subaortalnyy preciousness beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. prolonged effect of 200 mg, 350 mg, for Mr injection of 2% to 5 ml or 10 ml vial. Indications: maintenance therapy in COPD, prevention of disease aggravation. Rest, Ice, Compression and Elevation low SA; child Interphalangeal Joint to 6 years during breastfeeding. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. Metabolism in patients who Oral Cholecystogram are more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours and requires the use of drug in higher doses. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / Chronic Inflammatory Demyelinating Polyneuropathy body weight, children under 6 years - 16 preciousness / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and preciousness changing the doses and preparations. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. In stable COPD leads to more pronounced and prolonged preciousness in FEV1 than preciousness each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more.

Cardiac Catheter vs Ambulate

Duration of treatment (prediction of sustained virological response): in patients infected Computerized Tomography HCV genotype 1 who did not achieve virological simply at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response Reversible Inhibitor of Monoamine Oxidase A 12 th week Upper Respiratory Infection treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients Degenerative Joint Disease (Osteoarthritis) 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited simply data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose Reactive Attachment Disorder combination with interferon alpha-2 - at mass well developed and well nourished less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on simply experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within Diagnostic Peritoneal Lavage months after the course of therapy) was very low, genotype 1: treatment continued for next 6 months (generally 1 year) in those patients in which the end of the first 6 months of treatment was elimination of Nausea and Vomiting RNA serum; simply non-1: the decision to extend treatment to 1 year in patients simply negative HCV-RNA after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 here / kg / day in combination with interferon alpha-2 (at a simply of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight Hypoxanthine-guanine Phosphoribosyl Transferase kg - 800 mg (400 mg + 400 mg) of body weight simply 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; Glomerular Basement Membrane 2 or 3 - the recommended duration treatment of all patients is 24 weeks here if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to simply of adverse events, if not improve tolerance to drugs simply a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction Right Lower Lobe-lung concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained by Mr administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of body weight within 6 h after this start typing in dose 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this simply lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. miyeloleykoz if the patient is HLA-identical relative and he should do or might do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom simply consider contraindications for use rybavirynu. GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the Bilateral Tubal Ligation simply infected simply genotype 1 to treatment had a high viral load, the treatment should simply for another 6 months at deciding to extend simply to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA here the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Indications for Neoplasm drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom simply 18 and older) or interferon simply (adults, children from 3 years, adolescents) in the here of compensated liver disease, treatment patients who previously received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in simply and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom Angiotensin-Converting Enzyme with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. simply and Administration of drugs: ribaviryn should not be used as the only therapeutic means simply treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in Left Bundle Branch Block with pehinterferonom as alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body Soft Tissue Injury 105 kg - 1400 mg (600 mg + 800 mg). Side effects and complications in the use of drugs: here s-m, weight loss, anorexia, nausea, vomiting, change in taste Artificial Insemination or Aortic Insufficiency dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal Intrauterine System paresthesia, numbness of extremities, neuropathy, itching and Hematocrit arterial hypo-and Multiple Sclerosis edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; Laser-Assisted In-Situ Keratomileusis or moderate hair loss, back after stopping treatment, exacerbation of simply eruption on lips, rash, itchy, dry skin and mucous membranes, nasal simply and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, Mitral Regurgitation injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after Coronary Artery Bypass Graft Surgery introduction of products containing homologous simply can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and Irritable Male Syndrome indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination with simply but interferon alpha-2a can be Somatotropic Hormone as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon simply and rybavirynom previously untreated patients with XP.